ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
investment factor · long-only model fund

Foundry DelEqu Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FDELHYPOTHETICAL MODEL
Since ’99
+68%
Expense Ratio
0.29%
placeholder
Holdings
296
cap-weighted
Inception
Oct 2022
placeholder
Full Sharpe
0.19
Ann. Return (LS)
3.4%
Ann. Volatility
17.2%
Max Drawdown
-44.2%
Test Sharpe ’19–26
0.22
Test FF5 α (ann.)
4.6%
vs Fama-French 5
Test FF5 α t-stat
0.82
not significant
Monthly turnover
17%
of the long leg, per rebalance
Cumulative return (LS)
68%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.60
what this fund holds
Long leg ann. return
11.3%
buyable, long-only
Long-short Sharpe
0.19
requires shorting
Bottom bucket ann. return
7.9%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

296 of 296 · 100.0% of book
TickerCompanySectorMarket capWeight
1CRM
SALESFORCE INCTechnology$139.86B
9.53%
2FTNT
FORTINET INCTechnology$118.40B
8.07%
3HLT
HILTON WORLDWIDE HOLDINGS INCConsumer Cyclical$73.15B
4.98%
4TDG
TRANSDIGM GROUP INCIndustrials$67.93B
4.63%
5MSCI
MSCI INCFinancial Services$45.77B
3.12%
6CMG
CHIPOTLE MEXICAN GRILL INCConsumer Cyclical$44.18B
3.01%
7RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
2.70%
8WDAY
WORKDAY INCTechnology$35.76B
2.44%
9ZTS
ZOETIS INCHealthcare$32.10B
2.19%
10FICO
FAIR ISAAC CORPTechnology$29.15B
1.99%
11TPR
TAPESTRY INCConsumer Cyclical$28.58B
1.95%
12ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
1.82%
13VRSK
VERISK ANALYTICS INCIndustrials$26.29B
1.79%
14VRSN
VERISIGN INCTechnology$25.27B
1.72%
15MRNA
MODERNA INCHealthcare$24.53B
1.67%
16TEAM
ATLASSIAN CORPTechnology$23.67B
1.61%
17UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
1.55%
18RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
1.50%
19IP
INTERNATIONAL PAPER COConsumer Cyclical$19.89B
1.35%
20FTV
FORTIVE CORPTechnology$18.83B
1.28%
21DD
DUPONT DE NEMOURS INCBasic Materials$18.49B
1.26%
22BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
1.09%
23CSL
CARLISLE COMPANIES INCBasic Materials$13.98B
0.95%
24IVZ
INVESCO LTDFinancial Services$13.13B
0.89%
25PINS
PINTEREST INCCommunication Services$13.00B
0.89%
26MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.87%
27COKE
COCA-COLA CONSOLIDATED INCConsumer Defensive$12.03B
0.82%
28OC
OWENS CORNINGBasic Materials$11.59B
0.79%
29CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.73%
30CYTK
CYTOKINETICS INCHealthcare$9.98B
0.68%
31WLK
WESTLAKE CORPBasic Materials$9.95B
0.68%
32PSKY
PARAMOUNT SKYDANCE CORPCommunication Services$9.79B
0.67%
33MANH
MANHATTAN ASSOCIATES INCTechnology$9.66B
0.66%
34IT
GARTNER INCTechnology$9.39B
0.64%
35HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.63%
36GKOS
GLAUKOS CORPHealthcare$9.21B
0.63%
37LB
LANDBRIDGE CO LLCEnergy$8.89B
0.61%
38IBRX
IMMUNITYBIO INCHealthcare$8.04B
0.55%
39RAL
RALLIANT CORPTechnology$7.85B
0.53%
40HXL
HEXCEL CORPIndustrials$7.83B
0.53%
41MBLY
MOBILEYE GLOBAL INCConsumer Cyclical$7.76B
0.53%
42TAP
MOLSON COORS BEVERAGE COConsumer Defensive$7.28B
0.50%
43DBX
DROPBOX INCTechnology$7.14B
0.49%
44PAYC
PAYCOM SOFTWARE INCTechnology$7.05B
0.48%
45RIOT
RIOT PLATFORMS INCFinancial Services$6.91B
0.47%
46FLR
FLUOR CORPIndustrials$6.86B
0.47%
47CAG
CONAGRA BRANDS INCConsumer Defensive$6.83B
0.47%
48CROX
CROCS INCConsumer Cyclical$6.81B
0.46%
49CHE
CHEMED CORPHealthcare$6.77B
0.46%
50CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.45%
51MORN
MORNINGSTAR INCFinancial Services$6.56B
0.45%
52CVLT
COMMVAULT SYSTEMS INCTechnology$6.10B
0.42%
53MIDD
MIDDLEBY CORPIndustrials$6.02B
0.41%
54TFX
TELEFLEX INCHealthcare$5.96B
0.41%
55RIG
TRANSOCEAN LTDEnergy$5.74B
0.39%
56STEP
STEPSTONE GROUP INCFinancial Services$5.20B
0.35%
57CRC
CALIFORNIA RESOURCES CORPEnergy$4.69B
0.32%
58LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.30%
59TENB
TENABLE HOLDINGS INCTechnology$4.40B
0.30%
60CELC
CELCUITY INCHealthcare$4.31B
0.29%
61VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.29%
62EXLS
EXLSERVICE HOLDINGS INCTechnology$4.30B
0.29%
63PII
POLARIS INCConsumer Cyclical$4.16B
0.28%
64PLNT
PLANET FITNESS INCConsumer Cyclical$4.16B
0.28%
65MARA
MARA HOLDINGS INCFinancial Services$4.08B
0.28%
66DOCS
DOXIMITY INCHealthcare$3.94B
0.27%
67POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.27%
68WING
WINGSTOP INCConsumer Cyclical$3.88B
0.26%
69YETI
YETI HOLDINGS INCConsumer Cyclical$3.87B
0.26%
70RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.26%
71LOPE
GRAND CANYON EDUCATION INCConsumer Defensive$3.72B
0.25%
72DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.25%
73CCC
CCC INTELLIGENT SOLUTIONS HOLDINGS INCTechnology$3.55B
0.24%
74AB
ALLIANCEBERNSTEIN HOLDING LPFinancial Services$3.54B
0.24%
75LBTYA
LIBERTY GLOBAL LTDCommunication Services$3.52B
0.24%
76CLSK
CLEANSPARK INCFinancial Services$3.34B
0.23%
77ACHC
ACADIA HEALTHCARE COMPANY INCHealthcare$3.17B
0.22%
78UAA
UNDER ARMOUR INCConsumer Cyclical$3.17B
0.22%
79IDYA
IDEAYA BIOSCIENCES INCHealthcare$3.16B
0.22%
80CARG
CARGURUS INCConsumer Cyclical$3.16B
0.22%
81FSK
FS KKR CAPITAL CORPFinancial Services$3.06B
0.21%
82EXPO
EXPONENT INCIndustrials$3.05B
0.21%
83AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.21%
84LUNR
INTUITIVE MACHINES INCIndustrials$2.93B
0.20%
85RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.20%
86LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.20%
87XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.19%
88CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.19%
89GRND
GRINDR INCTechnology$2.71B
0.18%
90NGVT
INGEVITY CORPBasic Materials$2.66B
0.18%
91RUM
RUMBLE INCTechnology$2.51B
0.17%
92PBI
PITNEY BOWES INCIndustrials$2.51B
0.17%
93TALO
TALOS ENERGY INCEnergy$2.49B
0.17%
94ATRO
ASTRONICS CORPIndustrials$2.41B
0.16%
95BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.16%
96AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.16%
97BHVN
BIOHAVEN LTDHealthcare$2.32B
0.16%
98INTA
INTAPP INCTechnology$2.24B
0.15%
99NOG
NORTHERN OIL & GAS INCEnergy$2.24B
0.15%
100SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.15%
101AGL
AGILON HEALTH INCHealthcare$2.17B
0.15%
102AIN
ALBANY INTERNATIONAL CORPConsumer Cyclical$2.12B
0.14%
103GT
GOODYEAR TIRE & RUBBER COConsumer Cyclical$2.10B
0.14%
104CDNA
CAREDX INCHealthcare$2.05B
0.14%
105NUVB
NUVATION BIO INCHealthcare$2.03B
0.14%
106SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.14%
107PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.14%
108URGN
UROGEN PHARMA LTDHealthcare$1.96B
0.13%
109GSHD
GOOSEHEAD INSURANCE INCFinancial Services$1.93B
0.13%
110NGL
NGL ENERGY PARTNERS LPEnergy$1.89B
0.13%
111WKC
WORLD KINECT CORPEnergy$1.87B
0.13%
112MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.13%
113SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.13%
114MQ
MARQETA INCTechnology$1.85B
0.13%
115FUN
SIX FLAGS ENTERTAINMENT CORPORATIONConsumer Cyclical$1.79B
0.12%
116NN
NEXTNAV INCTechnology$1.78B
0.12%
117ASAN
ASANA INCTechnology$1.77B
0.12%
118ZYME
ZYMEWORKS INCHealthcare$1.77B
0.12%
119BFLY
BUTTERFLY NETWORK INCHealthcare$1.73B
0.12%
120FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.11%
121VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.11%
122NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.11%
123ENOV
ENOVIS CORPIndustrials$1.56B
0.11%
124CNXC
CONCENTRIX CORPTechnology$1.49B
0.10%
125PRGO
PERRIGO CO PLCHealthcare$1.48B
0.10%
126MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.10%
127YELP
YELP INCCommunication Services$1.44B
0.10%
128ECVT
ECOVYST INCBasic Materials$1.41B
0.10%
129WBTN
WEBTOON ENTERTAINMENT INCTechnology$1.41B
0.10%
130BRBR
BELLRING BRANDS INCConsumer Defensive$1.41B
0.10%
131FMC
FMC CORPBasic Materials$1.40B
0.10%
132AI
C3AI INCTechnology$1.37B
0.09%
133CXM
SPRINKLR INCTechnology$1.37B
0.09%
134DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.09%
135HLIT
HARMONIC INCTechnology$1.31B
0.09%
136XNCR
XENCOR INCHealthcare$1.30B
0.09%
137ABSI
ABSCI CORPHealthcare$1.29B
0.09%
138INBX
INHIBRX BIOSCIENCES INCHealthcare$1.28B
0.09%
139AMPL
AMPLITUDE INCTechnology$1.27B
0.09%
140QDEL
QUIDELORTHO CORPHealthcare$1.19B
0.08%
141MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.08%
142SDGR
SCHRODINGER INCHealthcare$1.14B
0.08%
143EYPT
EYEPOINT INCHealthcare$1.12B
0.08%
144SECZ
SECURITIZE CORPTechnology$1.11B
0.08%
145PRCT
PROCEPT BIOROBOTICS CORPHealthcare$1.09B
0.07%
146PCT
PURECYCLE TECHNOLOGIES INCIndustrials$1.09B
0.07%
147CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.07%
148NMAX
NEWSMAX INCCommunication Services$1.08B
0.07%
149GRPN
GROUPON INCCommunication Services$1.06B
0.07%
150AEVA
AEVA TECHNOLOGIES INCConsumer Cyclical$1.05B
0.07%
151AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.07%
152PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.07%
153VOR
VOR BIOPHARMA INCHealthcare$980M
0.07%
154SMPL
SIMPLY GOOD FOODS COConsumer Defensive$980M
0.07%
155KURA
KURA ONCOLOGY INCHealthcare$964M
0.07%
156ANNX
ANNEXON INCHealthcare$950M
0.06%
157AOSL
ALPHA & OMEGA SEMICONDUCTOR LTDTechnology$936M
0.06%
158GO
GROCERY OUTLET HOLDING CORPConsumer Defensive$934M
0.06%
159WRLD
WORLD ACCEPTANCE CORPFinancial Services$891M
0.06%
160REPL
REPLIMUNE GROUP INCHealthcare$859M
0.06%
161NX
QUANEX BUILDING PRODUCTS CORPBasic Materials$835M
0.06%
162FOXF
FOX FACTORY HOLDING CORPConsumer Cyclical$798M
0.05%
163CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.05%
164BBNX
BETA BIONICS INCHealthcare$771M
0.05%
165WEST
WESTROCK COFFEE COConsumer Defensive$749M
0.05%
166IBTA
IBOTTA INCTechnology$734M
0.05%
167CLYM
CLIMB BIO INCHealthcare$727M
0.05%
168AURA
AURA BIOSCIENCES INCHealthcare$723M
0.05%
169CBLL
CERIBELL INCHealthcare$710M
0.05%
170SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.05%
171NMFC
NEW MOUNTAIN FINANCE CORPFinancial Services$672M
0.05%
172VTS
VITESSE ENERGY INCEnergy$664M
0.05%
173CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.04%
174HELE
HELEN OF TROY LTDConsumer Defensive$655M
0.04%
175EVH
EVOLENT HEALTH INCHealthcare$654M
0.04%
176KLC
KINDERCARE LEARNING COMPANIES INCConsumer Defensive$618M
0.04%
177TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.04%
178FAC
FACTORIAL ENERGY INCIndustrials$610M
0.04%
179NGNE
NEUROGENE INCHealthcare$590M
0.04%
180ALIT
ALIGHT INCTechnology$584M
0.04%
181MYGN
MYRIAD GENETICS INCHealthcare$584M
0.04%
182IIIV
I3 VERTICALS INCTechnology$579M
0.04%
183RYAM
RAYONIER ADVANCED MATERIALS INCBasic Materials$555M
0.04%
184EGY
VAALCO ENERGY INCEnergy$553M
0.04%
185NPCE
NEUROPACE INCHealthcare$548M
0.04%
186YEXT
YEXT INCTechnology$535M
0.04%
187TOI
ONCOLOGY INSTITUTE INCHealthcare$535M
0.04%
188TASK
TASKUS INCTechnology$534M
0.04%
189KELYA
KELLY SERVICES INCIndustrials$531M
0.04%
190ARVN
ARVINAS INCHealthcare$517M
0.04%
191DNA
GINKGO BIOWORKS HOLDINGS INCHealthcare$517M
0.04%
192RGNX
REGENXBIO INCHealthcare$511M
0.03%
193NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.03%
194OIS
OIL STATES INTERNATIONAL INCEnergy$507M
0.03%
195NRC
NRC HEALTHHealthcare$491M
0.03%
196SGMT
SAGIMET BIOSCIENCES INCHealthcare$479M
0.03%
197GTEN
GORES HOLDINGS X INCIndustrials$472M
0.03%
198PRTA
PROTHENA CORP PUBLIC LTD COHealthcare$453M
0.03%
199KYTX
KYVERNA THERAPEUTICS INCHealthcare$453M
0.03%
200STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.03%
201CCRN
CROSS COUNTRY HEALTHCARE INCHealthcare$428M
0.03%
202ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.03%
203NPAC
NEW PROVIDENCE ACQUISITION CORP IIIIndustrials$399M
0.03%
204STRO
SUTRO BIOPHARMA INCHealthcare$391M
0.03%
205WENN
WEN ACQUISITION CORPIndustrials$387M
0.03%
206MGPI
MGP INGREDIENTS INCConsumer Defensive$382M
0.03%
207CVEO
CIVEO CORPIndustrials$382M
0.03%
208UPB
UPSTREAM BIO INCHealthcare$382M
0.03%
209EOLS
EVOLUS INCHealthcare$377M
0.03%
210CEPT
CANTOR EQUITY PARTNERS II INCIndustrials$376M
0.03%
211ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.02%
212SDHI
SIDDHI ACQUISITION CORP (CAYMAN ISLANDS)Industrials$364M
0.02%
213TACH
TITAN ACQUISITION CORPIndustrials$360M
0.02%
214IPCX
INFLECTION POINT ACQUISITION CORP IIIIndustrials$359M
0.02%
215SOUL
SOULPOWER ACQUISITION CORPIndustrials$352M
0.02%
216SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.02%
217XRPN
ARMADA ACQUISITION CORP IIIndustrials$330M
0.02%
218RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.02%
219XPOF
XPONENTIAL FITNESS INCConsumer Cyclical$328M
0.02%
220VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.02%
221OBA
OXLEY BRIDGE ACQUISITION LTDIndustrials$325M
0.02%
222SZZL
SIZZLE ACQUISITION CORP IIIndustrials$325M
0.02%
223PESI
PERMA FIX ENVIRONMENTAL SERVICES INCIndustrials$324M
0.02%
224TVA
TEXAS VENTURES ACQUISITION III CORPIndustrials$316M
0.02%
225LYEL
LYELL IMMUNOPHARMA INCHealthcare$311M
0.02%
226PAMT
PAMT CORPIndustrials$311M
0.02%
227PSBD
PALMER SQUARE CAPITAL BDC INCFinancial Services$306M
0.02%
228ALCO
ALICO INCConsumer Defensive$304M
0.02%
229OPTX
SYNTEC OPTICS HOLDINGS INCTechnology$302M
0.02%
230JENA
JENA ACQUISITION CORP IIIndustrials$301M
0.02%
231PACH
PIONEER ACQUISITION I CORPIndustrials$293M
0.02%
232NXDT
NEXPOINT DIVERSIFIED REAL ESTATE TRUSTReal Estate$291M
0.02%
233TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.02%
234PAII
PYROPHYTE ACQUISITION CORP IIIndustrials$279M
0.02%
235MASS
908 DEVICES INCHealthcare$278M
0.02%
236SGHT
SIGHT SCIENCES INCHealthcare$274M
0.02%
237CEPO
CANTOR EQUITY PARTNERS I INCIndustrials$271M
0.02%
238TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.02%
239HCKT
HACKETT GROUP INCTechnology$261M
0.02%
240SRZN
SURROZEN INCHealthcare$255M
0.02%
241LMNR
LIMONEIRA COConsumer Defensive$245M
0.02%
242RNAC
CARTESIAN THERAPEUTICS INCHealthcare$243M
0.02%
243ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.02%
244MCGA
YORKVILLE ACQUISITION CORPIndustrials$241M
0.02%
245GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.02%
246SMTI
SANARA MEDTECH INCHealthcare$229M
0.02%
247FC
FRANKLIN COVEY COIndustrials$229M
0.02%
248UP
WHEELS UP EXPERIENCE INCIndustrials$229M
0.02%
249ONCH
1RT ACQUISITION CORPIndustrials$222M
0.02%
250KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.01%
251KROS
KEROS THERAPEUTICS INCHealthcare$211M
0.01%
252FOCL
FOCAL INCHealthcare$204M
0.01%
253FORR
FORRESTER RESEARCH INCIndustrials$200M
0.01%
254AMWL
AMERICAN WELL CORPHealthcare$199M
0.01%
255SRI
STONERIDGE INCConsumer Cyclical$197M
0.01%
256COOK
TRAEGER INCConsumer Cyclical$193M
0.01%
257EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.01%
258KRRO
KORRO BIO INCHealthcare$177M
0.01%
259ARCT
ARCTURUS THERAPEUTICS HOLDINGS INCHealthcare$172M
0.01%
260NLOP
NET LEASE OFFICE PROPERTIESReal Estate$172M
0.01%
261MRDN
MERIDIAN HOLDINGS INCCommunication Services$171M
0.01%
262KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.01%
263SPEG
SILVER PEGASUS ACQUISITION CORPIndustrials$158M
0.01%
264RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
265EXOD
EXODUS MOVEMENT INCTechnology$152M
0.01%
266HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
267CHPT
CHARGEPOINT HOLDINGS INCConsumer Cyclical$146M
0.01%
268DMRC
DIGIMARC CORPTechnology$133M
0.01%
269OCC
OPTICAL CABLE CORPTechnology$130M
0.01%
270FIRY
FIRY INCTechnology$130M
0.01%
271AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
272INSG
INSEEGO CORPTechnology$122M
0.01%
273SAMG
SILVERCREST ASSET MANAGEMENT GROUP INCFinancial Services$118M
0.01%
274TCX
TUCOWS INCTechnology$114M
0.01%
275STHO
STAR HOLDINGSReal Estate$114M
0.01%
276CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.01%
277CHRN
CHRONOSCALE CORPIndustrials$94M
0.01%
278GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.01%
279FVN
FUTURE VISION II ACQUISITION CORPIndustrials$83M
0.01%
280AEYE
AUDIOEYE INCTechnology$82M
0.01%
281BARK
BARK INCConsumer Cyclical$82M
0.01%
282PIII
P3 HEALTH PARTNERS INCHealthcare$78M
0.01%
283SEAT
VIVID SEATS INCCommunication Services$78M
0.01%
284WTG
WINTERGREEN ACQUISITION CORPIndustrials$76M
0.01%
285ACET
ADICET BIO INCHealthcare$76M
0.01%
286CLNN
CLENE INCHealthcare$76M
0.01%
287SCLX
SCILEX HOLDING COHealthcare$72M
0.00%
288NDLS
NOODLES & COConsumer Cyclical$66M
0.00%
289BGSF
BGSF INCIndustrials$65M
0.00%
290BRID
BRIDGFORD FOODS CORPConsumer Defensive$59M
0.00%
291EDSA
EDESA BIOTECH INCHealthcare$59M
0.00%
292SKIL
SKILLSOFT CORPConsumer Defensive$58M
0.00%
293RIBB
RIBBON ACQUISITION CORPIndustrials$54M
0.00%
294MCRB
SERES THERAPEUTICS INCHealthcare$52M
0.00%
295EXOZ
EXOZYMES INCHealthcare$51M
0.00%
296TIL
INSTIL BIO INCHealthcare$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.47T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
33.3%
Healthcare
20.5%
Consumer Cyclical
16.9%
Industrials
11.3%
Financial Services
6.5%
Basic Materials
4.2%
Communication Services
2.6%
Consumer Defensive
2.6%
Energy
2.1%
Real Estate
0.1%

Portfolio Style

Size × value map of the long-leg book

296 classified
Value
Blend
Growth
Large
Mid
Small
14%6
16%16
40%19
3%16
5%35
4%26
1%45
1%18
1%37

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 90% toward Large, 66% toward Growth. +15% unclassified (78 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt90% → Large
SmallLarge
Value ↔ growth tilt66% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 296 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    30.6%
    Margin
    -5.6%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 296 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.3 (95% CI 1.0-1.4)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
12.5%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.29x
within
parametric
1.18x
within
cornish fisher
1.15x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2005
Before publication (pre-2005)
0.08
Sharpe · 2.1% p.a.
January 1999December 2005 · 84 mo
Since publication
0.28
Sharpe · 3.8% p.a.
January 2006July 2026 · 247 mo
Change in Sharpe+0.20Sharpe strengthened since publication

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
65%
17 of 26 3-year windows made money
Worst window
-0.91
Sharpe, January 2002 – December 2004
January 1999July 2026
Median Sharpe
0.27
Dispersion
0.57
Best window
1.18

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.34.0%16.4%
3 yearsp.a.21.2%-7.3%
5 yearsp.a.14.8%5.4%
10 yearsp.a.16.4%3.3%
Since inceptionp.a.9.9%1.9%
Calendar years
YearLong legLong-short
20267 mo17.4%4.8%
202517.2%-5.9%
202429.9%-18.3%
202331.1%-9.8%
2022-16.5%52.7%
202119.5%32.4%
202022.2%-17.3%
201927.3%-1.5%
2018-3.7%12.7%
201722.6%-6.2%
201622.2%22.5%
20150.7%1.0%
201416.4%3.0%
201339.4%7.8%
201219.8%-0.8%
20117.3%6.7%
201020.8%-0.3%
200936.7%-19.1%
2008-36.1%30.5%
20075.9%-14.8%
200615.5%9.4%
20050.9%-6.3%
2004-0.7%-17.1%
200345.7%2.1%
2002-40.1%-14.8%
2001-14.0%34.9%
2000-1.7%61.6%
199929.8%-37.0%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FDEL
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2022-10-03 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.47T

Methodology

The Foundry DelEqu Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a DelEqu signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.